News
Ex-Novartis CMO John Tsai joins Daiichi Sankyo
Daiichi Sankyo has named John Tsai as its new chief medical officer, replacing Ken Takeshita, who is stepping down after five years in the role.
News
MSD and Mayo Clinic team up on AI drug discovery
MSD has signed an industry-first deal with the Mayo Clinic that will allow it to use the health system's genomic and clinical data for drug discovery.
News
Number of UK biotech companies rising, says report
A report has found that the number of life sciences companies domiciled in the UK has grown by nearly a quarter in the last few years.
News
Novartis' oral BTK drug moves the needle in CINDU
Novartis is set to expand the label for its oral BTK inhibitor Rhapsido, keeping the drug on course to become one of its biggest-ever brands.
R&D
Changing Faces: Board of Directors, January 2026
January was a relatively quiet month for Board news, but there were some notable moves here and there.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
